Therefore, in this study, we evaluated the expression of complement regulatory proteins CD35, CD46, CD55, and CD59 on granulocytes, lymphocytes, and monocytes of CAD patients and healthy donors. The gene discussed is CD55; the disease is coronary artery disorder.